M) induced a concentration-dependent decrease in atrial rate that was similar in atria from M 3-receptor knockout and wild-type mice, indicating that M 3 receptors were not involved in muscarinic receptor-mediated atrial rate decreases. In contrast, the M 3 receptor was a major muscarinic receptor involved in smooth muscle contraction of stomach fundus, urinary bladder, and trachea, although differences existed in the extent of M 3-receptor involvement among the tissues. Contraction to carbamylcholine was virtually abolished in urinary bladder from M 3-receptor knockout mice, suggesting that contraction was predominantly due to M 3-receptor activation. However, ϳ50-60% maximal contraction to carbamylcholine occurred in stomach fundus and trachea from M 3-receptor knockout mice, indicating that contraction in these tissues was also due to M 2-receptor activation. High concentrations of carbamylcholine relaxed the stomach fundus from M 3-receptor knockout mice by M1-receptor activation. Thus M 3-receptor knockout mice provided unambiguous evidence that M 3 receptors 1) play no role in carbamylcholine-induced atrial rate reduction, 2) are the predominant receptor mediating carbamylcholine-induced urinary bladder contractility, and 3) share contractile responsibility with M 2 receptors in mouse stomach fundus and trachea. atrial rate; negative chronotropy; smooth muscle contraction; carbamylcholine-mediated responses IN MANY SMOOTH MUSCLE PREPARATIONS where the muscarinic receptor population was resolved through antagonist radioligand-binding studies (6), M 2 receptors comprised 70-80% and M 3 receptors 20-30% of the receptor population. Although they are only a small proportion of the receptors, previous pharmacological studies indicated that muscarinic receptor-induced contractile responses in several smooth muscles were likely mediated by activation of M 3 receptors (3, 6, 7). In addition, selective inactivation of M 3 receptors by 4-DAMP mustard revealed a role for M 2 receptors in smooth muscle contraction (7). Thus, with the availability of mutant mouse strains lacking functional M 1 , M 2 , M 3 , and M 4 receptors (9, 10, 12, 24, 33) , the physiological role of muscarinic receptors in native tissue can be unambiguously determined.
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In previous studies comparing smooth muscle contractile responses in M 2 -and M 4 -receptor knockout mice with responses in wild-type littermates, carbamylcholine-induced contractile potency was reduced in stomach fundus, urinary bladder, and tracheal preparations only from M 2 -receptor knockout mice, indicating a role for M 2 , but not M 4 , receptors in smooth muscle contraction (33) . However, in tissues from M 2 -receptor knockout mice, maximal contraction to carbamylcholine was not altered, suggesting a prominent contractile role for another cholinergic receptor. Recently, Matsui et al. (24) demonstrated marked impairment of the contractile response to carbamylcholine in ileum and urinary bladder from mutant mice lacking M 3 receptors. Whether M 3 receptors are also important in other smooth muscle preparations such as stomach fundus and trachea has not been examined in M 3 -receptor knockout mice. The fact that M 3 receptors have been implicated in the regulation of intracellular calcium in stomach fundus (31) also raised the possibility of an important role for M 3 receptors in smooth muscle contractility.
Mammalian heart is comprised predominantly of M 2 -muscarinic receptors (3), as determined by the localization of M 2 -receptor mRNA in rat heart by in situ hybridization (16) and, more recently, by the requirement of functional M 2 receptors in muscarinic receptor-dependent atrial rate reduction (33) . Nonetheless, expression of M 3 -muscarinic receptor genes in guinea pig and rat intrinsic intracardiac neurons by in situ hybridization (13) and in canine atria (30) and human heart (14, 36) by reverse transcription-polymerase chain reaction (30) has been described. In addition, on the basis of studies with isolated myocytes, Wang and colleagues (37) suggested that M 3 receptors mediated a potassium current involved in mammalian heart rate. However, no direct evidence exists for the role of these gene products in the regulation of atrial rate.
On the basis of the possible role of M 3 receptors in atrial rate and smooth muscle contractility, the present study focused on comparing responses to carbamylcholine in isolated atria and three smooth muscle preparations (stomach fundus, urinary bladder, and trachea). Our results indicate, in a direct and unequivocal manner, that M 3 receptors are not involved in carbamylcholine-induced decreases in atrial rate but are essential for carbamylcholine-induced smooth muscle contraction, most prominently in the urinary bladder. Unanticipated findings from this study were 1) the substantial residual contraction to carbamylcholine in the stomach fundus and trachea from M 3 -receptor knockout mice, indicative of pronounced M 2 -receptor activation by carbamylcholine, and 2) the exposure of an M 1 -receptor-mediated relaxation in the stomach fundus. These results emphasize the utility of muscarinic receptor knockout mice to evaluate the involvement of distinct muscarinic receptor subtypes in physiological functions.
METHODS

Animals.
The generation of M3-muscarinic receptor knockout mice has been described previously (38) . Male M3-receptor knockout and wild-type mice of the same genetic background used in the present study were obtained from the National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, MD) or Taconic (Germantown, NY). Animals were housed in polycarbonate ventilated cages. The animal room was maintained at 22-24°C with a relative humidity of 35-70% and daily light-dark cycle (lights on from 0600 to 1800). Dry pellet food (Laboratory Rodent Diet 5001, PMI Feed) and water were supplied ad libitum. Body weights of age-matched M 3-receptor knockout and wild-type mice were measured with a balance (model D 1001 CA, Ohaus, Pine Brook, NJ). Mice were then killed by cervical dislocation, and the heart, stomach fundus, urinary bladder, and/or trachea were quickly excised and placed in modified Krebs bicarbonate buffer solution of the following composition (mM): 4. Atrial preparation. Spontaneously beating atria were dissected from ventricles, and the left atrium was attached with thread to a stationary glass rod, while the right atrium was tied with thread to a force displacement transducer. The atria were placed in organ baths containing 10 ml of bicarbonate buffer (see Animals for composition). The organ bath solution was maintained at 37°C and aerated with 95% O 2-5% CO2. The spontaneously beating atria were placed under an initial force of 0.5 g and equilibrated for 20 min, during which time the tissues were washed at 5-min intervals, as reported previously (32, 33) . Atrial rate in beats per minute was measured with transducers (model MBL55140-02, Sensotec, Columbus, OH) that were coupled to a Compaq Deskpro-compatible data-acquisition system (BIOPAC Systems, Goleta, CA). Cumulative concentration-response curves to 10 Ϫ8 -10 Ϫ5 M carbamylcholine chloride (Sigma Chemical, St. Louis, MO) were generated and expressed as a percentage of the initial atrial rate.
Smooth muscle preparations. A longitudinal section of stomach fundus, the urinary bladder body (cut from the urethral opening to the dome), and a 5-mm length of trachea were prepared for in vitro examination. One end of the stomach fundus or urinary bladder was attached with thread to a stationary glass rod, while the other end was tied with thread to the transducer. Tracheal rings were mounted on hooks that were gently separated so that the lower hook was attached with thread to a stationary rod, while the upper hook was tied with thread to the transducer. All tissues were placed in organ baths containing 10 ml of bicarbonate buffer (see Animals for composition). The organ bath solution was maintained at 37°C and aerated with 95% O2-5% CO2. Smooth muscle preparations were placed under an initial optimal force of 2.0 g for tracheal rings and 4.0 g for stomach fundus and urinary bladder, as determined in length-tension optimizing studies with each preparation (33) , and equilibrated for 1 h, during which time the tissues were washed at 15-min intervals. Isometric force in grams was measured with Sensotec transducers. Stomach fundus, urinary bladder, and trachea were initially challenged with 67 mM KCl to confirm viability of the preparation. Cumulative contractile concentration-response curves to 10 Ϫ8 -3.0 ϫ 10 Ϫ5 M carbamylcholine were generated and expressed as a percentage of the 67 mM KCl-induced contraction determined for each tissue. On each day, tissues from M3-receptor knockout and wild-type mice were used to avoid the possibility of any daily systematic effect. Experiments were performed over multiple days.
In other experiments, stomach fundus from M3-receptor knockout mice was incubated with 3.0 ϫ 10 Ϫ7 M pirenzepine dihydrochloride (Sigma Chemical) or vehicle for 20 min, and contractile concentration-response curves to 10 Ϫ8 -3.0 ϫ 10 Ϫ5 M carbamylcholine were generated. Peak contraction to carbamylcholine occurred at 10 Ϫ6 M, and higher concentrations of carbamylcholine (3.0 ϫ 10 Ϫ6 -3.0 ϫ 10 Ϫ5 M) relaxed the stomach fundus. The effect of pirenzepine on the relaxant response to carbamylcholine was examined in stomach fundus and measured as percent relaxation of the maximum contraction to 10 Ϫ6 M carbamylcholine. Carbamylcholineinduced contraction and relaxation were similar before and after vehicle incubation in all tissues studied.
Statistical analyses. Values are means Ϯ SE of three to nine isolated tissues obtained from three to nine animals. Carbamylcholine concentration-response curves were analyzed by a three-parameter logistic nonlinear model (4). The three modeled parameters included the maximal response of the tissue, the EC50, and the slope of the curves. Each curve was fitted using SAS software (SAS Institute, Cary, NC). Two-way repeated-measures ANOVA was used to compare carbamylcholine responses in stomach fundus, urinary bladder, and trachea between wild-type and M3-receptor knockout mice and to examine the effect of 3.0 ϫ 10 Ϫ7 M pirenzepine on carbamylcholine-induced relaxation in stomach fundus from M3-receptor knockout mice. Bonferroni's correction was performed to control for multiple comparisons. Unpaired Student's t-test was used to compare mean atrial rates, mean tissue KCl contractile responses, and mean pEC50 (Ϫlog EC50) values to carbamylcholine between M3-receptor knockout and wild-type mice using SigmaStat for Windows (version 2.03, SPSS Science, Chicago, IL). Comparisons were considered significant for P Յ 0.05.
RESULTS
Age and body weight comparisons between M 3 -receptor knockout and wild-type mice.
The M 3 -receptor knockout mice did not significantly differ in age from wild-type mice: 23.5 Ϯ 2.6 and 18.9 Ϯ 3.7 wk, respectively (P ϭ 0.30). In contrast, mean body weights of M 3 -receptor knockout mice were significantly lower than mean body weights of wild-type mice: 30.7 Ϯ 1.5 and 35.7 Ϯ 1.6 g, respectively (P Ͻ 0.05).
Basal atrial rate in M 3 -receptor knockout and wildtype mice. Basal rates of spontaneously beating mouse atria from the M 3 -receptor knockout mice were not different from atrial rates in wild-type mice: 472.9 Ϯ 14.1 and 451.8 Ϯ 12.0 beats/min, respectively. The similarity in basal atrial rate between the two groups indicates that M 3 receptors do not modulate basal sinoatrial nodal function in vitro.
Carbamylcholine-induced negative chronotropy. The potency and maximal decrease in atrial rate to 10 Ϫ8 -10 Ϫ5 M carbamylcholine were comparable in atria from M 3 -receptor knockout and wild-type mice (pEC 50 ϭ 5.96 Ϯ 0.07 and 6.02 Ϯ 0.08, respectively; Fig. 1 ). This lack of difference in reduction in atrial rate to carbamylcholine between M 3 -receptor knockout and wild-type mice indicates that M 3 receptors do not play a role in the atrial negative chronotropic response to carbamylcholine.
Carbamylcholine-induced contraction in smooth muscle. Carbamylcholine (10 Ϫ8 -3.0 ϫ 10 Ϫ5 M) contracted the stomach fundus, urinary bladder, and trachea from M 3 -receptor knockout and wild-type mice (Fig. 2) . However, the characteristics of the contractile response to carbamylcholine differed among the tissues. In the stomach fundus and trachea, there was a marked reduction (ϳ50-60%) in the maximal response to carbamylcholine in tissues from M 3 -receptor knockout mice compared with wild-type mice, although the potency of carbamylcholine was not altered (Table 1 ). In the stomach fundus and trachea, although maximal contraction was reduced, a residual maximal contraction to carbamylcholine (ϳ50% of the contraction in tissue from wild-type mice) was apparent in tissues from the M 3 -receptor knockout mice.
Furthermore, in the stomach fundus but not the trachea, high concentrations of carbamylcholine (Ͼ10 Ϫ6 M) relaxed the preparations from M 3 -receptor knockout mice (Fig. 2) , an effect that did not occur in the trachea from M 3 -receptor knockout mice. In the presence of the M 1 -selective receptor antagonist pirenzepine (3.0 ϫ 10 Ϫ7 M), the relaxant response to high concentrations of carbamylcholine (Ͼ10 Ϫ6 M) in stom- ach fundus from M 3 -receptor knockout mice was abolished, indicating the involvement of M 1 -receptor activation in carbamylcholine-induced relaxation (Fig. 3) . In contrast to the stomach fundus and trachea, maximal carbamylcholine-induced contraction of urinary bladder was markedly diminished. Little residual contractile response to carbamylcholine (Ͻ10% of the contraction in tissue from wild-type mice) remained in urinary bladder from the M 3 -receptor knockout mice (Fig. 2, Table 1 ).
Although contractions to carbamylcholine were reduced in stomach fundus, urinary bladder, and trachea from M 3 -receptor knockout mice, 67 mM KCl-induced contraction did not statistically differ in stomach fundus, urinary bladder, and trachea from M 3 -receptor knockout and wild-type mice (Table 2) . Thus stomach fundus, urinary bladder, and trachea were responsive to a noncholinergic smooth muscle contractile agent, indicating that the deletion of M 3 receptors did not alter contractile machinery in these tissues.
DISCUSSION
The development of muscarinic-receptor knockout mice has permitted a detailed and unequivocal exploration of the role for each of the known muscarinic receptors to behavior (9, 10, 12, 26) and peripheral tissue responses (24, 33) . Interestingly, elimination of the M 3 receptor resulted in a pronounced reduction in body weight transiently (24) or over longer time periods (38; this study), an effect not reported in animals lacking other muscarinic receptors (9, 10, 12) . The reduction in body weight observed in M 3 -receptor knockout mice was associated with a decrease in dry food intake in these animals (24, 38; this study). The weight loss was previously attributed to altered hypothalamic responsiveness (38) . However, our study raises the possibility that delayed gastric emptying resulting from alterations in gastric motility in M 3 -receptor knockout mice might also contribute to the reduction in body weight in M 3 -receptor knockout mice. Support for this hypothesis comes from studies demonstrating that atropine delayed gastric emptying more in obese than in lean human subjects (35) , suggesting reduced gastric vagal cholinergic activity in lean subjects. This observation is consistent with decreased M 3 -receptor activation in gastrointestinal tissue contributing to decreased body weight. Thus, in addition to a central hypothalamic effect, reduced gastric contractility may also contribute to the reduction in body weight observed in M 3 -receptor knockout mice.
Peripheral muscarinic receptors are implicated in the control of numerous fundamental physiological processes such as heart rate regulation, glandular secretion, and smooth muscle contraction (2, 3, 17, 27) . In this study, we used M 3 receptor-deficient mice (24, 38) to study the potential role of this muscarinic receptor subtype in atrial rate and smooth muscle contractile responses in stomach fundus, urinary bladder, and trachea.
Initial studies documented a virtual loss of negative chronotropy to carbamylcholine in atria from M 2 -receptor knockout mice (33) , supporting a predominant role of the M 2 receptor in mediating carbamylcholine- induced atrial rate reduction. However, the M 3 receptor has also been strongly implicated in cardiac function on the basis of its localization (36) and reported role in altering potassium current in myocytes (37) . On the basis of these observations, we further explored the effects of carbamylcholine in atria from M 3 -receptor knockout mice. The present studies unequivocally document that carbamylcholine-induced lowering of atrial rate was unaffected by the absence of the M 3 receptor in mouse atria. It is possible that the M 3 receptor proposed to alter heart rate (37) does not reside in the mouse atria or the alteration in potassium currents produced by pilocarpine in canine and guinea pig myocytes (37) may have resulted from activation of other muscarinic receptor(s). Although Wang et al. (37) attempted to utilize concentrations of pharmacological tools selective for specific muscarinic receptors, the compounds used were relatively nonselective. Nevertheless, the present studies with M 3 -receptor knockout mice add further support to the important and predominant role of M 2 receptors in mediating atrial rate and convincingly document a lack of M 3 -receptor involvement. These studies do not, of course, address the role of M 3 receptors in atrioventricular node conduction or Purkinje fiber transmission, which could affect cardiac conduction and heart rate in the intact cardiac system, but they do support the use of isolated mouse atria for the study of selective M 2 -receptor agonists and antagonists.
Prior pharmacological investigations using mouse stomach fundus (25, 29) , urinary bladder (5, 23), and trachea (8, 15) have demonstrated muscarinic-induced contractile responses but have not detailed the multiple receptor subtypes involved. However, previous studies with muscarinic-receptor knockout mice demonstrated that M 2 , but not M 4 , receptors participated in smooth muscle contractility (33) . Carbamylcholine was significantly less potent (by ϳ2-fold) in contracting stomach fundus, urinary bladder, and trachea from M 2 -receptor knockout mice than from M 4 -receptor knockout or wild-type mice (33) . In addition, Matsui et al. (24) recently reported impaired contractility of urinary bladder and ileal smooth muscle preparations from M 3 -receptor knockout mice compared with wildtype mice. Taken in concert, these studies suggested an important role for M 2 and M 3 receptors in carbamylcholine-induced contraction in these tissues.
With the use of M 3 -receptor knockout mice, the current detailed examination of carbamylcholine-induced contraction revealed marked differences in responses among smooth muscle preparations from mutant mice. In the trachea from M 3 -receptor knockout mice, carbamylcholine produced a classical contractile response, albeit with significantly lower maximal contraction than in trachea from wild-type mice. Furthermore, maximal contraction was maintained as carbamylcholine concentration increased. A significant residual contraction to carbamylcholine (ϳ60% of the response in tissues from wild-type mice) remained even in the absence of M 3 receptors. This observation, coupled to the previous demonstration of decreased potency to carbamylcholine in trachea from M 2 -receptor knockout mice (33) , suggests that M 3 -receptor activation is required for maximal tracheal contractility to carbamylcholine, whereas M 2 -receptor activation increases sensitivity or potency to carbamylcholine.
In contrast, carbamylcholine-induced contraction was virtually abolished in urinary bladder from M 3 -receptor knockout mice, confirming the previous observation of Matsui et al. (24) . Thus, in urinary bladder, contraction to carbamylcholine is clearly and unequivocally mediated predominantly by activation of M 3 receptors. M 2 receptors play only a minor role in urinary bladder contractility to carbamylcholine (33) . Thus the urinary bladder may serve as a useful preparation to study the effects of compounds and their signaling mechanisms at endogenous M 3 receptors.
The carbamylcholine contractile response profile in the stomach fundus differed from that in the trachea or urinary bladder. In the absence of M 3 receptors, maximal contraction to carbamylcholine was markedly reduced (Ͻ50% of the maximal response in tissues from wild-type mice). Thus M 3 receptors play a predominant role in carbamylcholine-induced contraction in the stomach fundus. This observation was consistent with the previous demonstration that the M 3 -selective receptor antagonist zamifenacine suppressed gastric emptying in rats at a dose that did not alter heart rate (21). These results support our contention that blockade of the M 3 receptor will decrease gastric contractility, stomach emptying, and body weight, as observed in the M 3 -receptor knockout mice.
As the concentration of carbamylcholine was increased in stomach fundus from M 3 -receptor knockout mice, a relaxant effect was observed, an effect that was not as apparent in stomach fundus from wild-type mice or in trachea from M 3 -receptor knockout mice. Previous studies using stomach fundus from pig (20) and rat (19) documented neuronally induced nitric oxide-mediated relaxant responses. Such relaxant responses may be mediated by activation of M 1 (1, 18, 28) or M 4 (11) receptors, as documented with other smooth muscle preparations. Our results with the M 1 -selective receptor antagonist pirenzepine demonstrate that M 1 -receptor activation is likely the mechanism mediating carbamylcholine-induced relaxation in stomach fundus from M 3 -receptor knockout mice. These data document the presence of a relaxant cholinergic receptor in the stomach fundus that is most apparent in the absence of M 3 receptors.
Clearly, M 3 -receptor deletion affected contraction differentially in the three smooth muscle preparations. The fact that M 3 -receptor deletion reduced contraction to carbamylcholine in stomach fundus and trachea by only 50% may be related to activation of other muscarinic receptor contractile mechanisms. For example, activation of the M 2 receptor can inhibit adenylyl cyclase (3, 6, 7) , and inhibition of adenylyl cyclase has been associated with contractile effects for other receptor agonists in vascular smooth muscle (34) . Alternatively, activation of presynaptic M 2 receptors by acetylcholine has been proposed to inhibit nitric oxide release in cerebral blood vessels and thus reduce vasodilation (22) , which could translate into enhanced contractility. If a similar action were to occur in stomach fundus or trachea, enhanced contraction would likewise occur when carbamylcholine activated presynaptic M 2 receptors.
Thus, in stomach fundus, trachea, and urinary bladder, the maximal contractile response to carbamylcholine was diminished in tissues from M 3 -receptor knockout mice. The possibility can be raised that the marked reduction in contraction to carbamylcholine in smooth muscles from the M 3 -receptor knockout mice was related to the significantly reduced body weight of the M 3 -receptor knockout mice. However, this is unlikely, since 1) no change in basal atrial rate occurred between knockout and wild-type mice, 2) the contractile responses to carbamylcholine did not change in a uniform fashion among the smooth muscle preparations, and, lastly and most convincingly, 3) contraction to KCl was not significantly altered in tissues from the M 3 -receptor knockout mice. KCl has been used as a nonselective depolarizing agonist to standardize function in smooth muscle. Thus, although M 3 -receptor knockout mice were significantly smaller in body weight and tissue responsiveness to carbamylcholine was reduced, contraction to nonspecific agonists such as KCl was not similarly affected.
In conclusion, this study illustrates the usefulness of receptor knockout mice to examine the role of specific muscarinic receptor subtypes present in peripheral tissues. We showed, in a direct and unequivocal manner, that functional M 3 receptors are not involved in muscarinic receptor-dependent atrial rate reduction. The present study also demonstrated that M 3 receptors are the primary muscarinic receptor subtype mediating contraction in urinary bladder. In contrast, a considerable smooth muscle contractile response to carbamylcholine remained in stomach fundus and trachea from M 3 -receptor knockout mice, suggesting that, in these tissues, M 3 and M 2 receptors importantly contributed to muscarinic-induced contraction. Thus marked differences exist in the relative role of M 2 and M 3 receptors in the contraction produced by carbamylcholine in peripheral smooth muscle.
Perspectives
These results with smooth muscle from M 3 -receptor knockout mice coupled with previous studies using M 2 -receptor knockout mice (33) suggest that M 2 -and M 3 -receptor activation contributes to smooth muscle contractility, although the contribution of M 2 -receptor activation varies widely among tissues. The development of M 2/3 -double receptor knockout mice and the study of smooth muscle contractility from such animals would be required to test this hypothesis and definitively rule out a contractile role for other muscarinic receptors.
